Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic Medicaid population

Value in Health

Volumn 11, Issue 1, 2008, Pages 110-118

  Bae, Seung Jin ^a   Paltiel, A David ^b   Fuhlbrigge, Anne L ^c   Weiss, Scott T ^c   Kuntz, Karen M ^a,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Asthma; Copayment; Medicaid; Prescription drug

Indexed keywords

CORTICOSTEROID;

ARTICLE; ASTHMA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG UTILIZATION; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; MEDICAL DECISION MAKING; PRESCRIPTION; PRIORITY JOURNAL; SIMULATION;

EID: 38549111799     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2007.00219.x     Document Type: Article

References (46)

1. Gencarelli DM. Medicaid prescription drug coverage: state efforts to control costs. NHPF Issue Brief 2003 790 : 1 17.
2. Levit K, Smith C, Cowan C, et al. Trends in U.S. health care spending, 2001. Health Aff (Millwood) 2003 22 : 154 64.
3. Commonwealth of Massachusetts, Division of Medical Assistance. Provider Manual Series. Boston, MA : Division of Medical Assistance, 2003.
4. US Congress Office of Technology Assessment. Benefit Design in Health Care Reform; Background Paper- Patient Cost-Sharing, OTA-BP-H-112. Washington, DC : US Government Printing Office, 1993.
5. Soumerai SB, Ross-Degnan D, Fortess EE, et al. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. Milbank Q 1993 71 : 217 52.
6. Crowley J, Ashner D, Elam L. Medicaid Outpatient Prescription Drug Benefits: Findings from a National Survey. Washington, DC : The Henry J. Kaiser Family Foundation, 2003.
7. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001 285 : 421 9.
8. Newhouse JP. Free for All? Lessons from the Rand Health Insurance Experiment. Cambridge, MA : Harvard University Press, 1996.
9. Blais L, Couture J, Rahme E, et al. Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistance. Health Policy 2003 64 : 163 72.
10. Cunningham PJ. Medicaid cost containment and access to prescription drugs. Health Aff 2005 24 : 780 9.
11. Helms J, Newhouse JP, Phelps CE. Copayments and demand for medical care: the California Medicaid experience. Bell J Econ 1978 9 : 192 208.
12. Lexchin J, Grootendorst P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv 2004 34 : 101 22.
13. Stuart B, Zacker C. Who bears the burden of Medicaid drug co-payment policies? Health Aff (Millwood) 1999 18 : 201 12.
14. Kuntz KM, Kitch BT, Fuhlbrigge AL, et al. A novel approach to defining the relationship between lung function and symptom status in asthma. J Clin Epidemiol 2002 55 : 11 18.
15. Fuhlbrigge AL, Kitch BT, Paltiel AD, et al. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001 107 : 61 7.
16. Paltiel AD, Fuhlbrigge AL, Kitch BT, et al. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001 108 : 39 46.
17. Kitch BT, Paltiel AD, Kuntz KM, et al. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Chest 2004 126 : 1875 82.
18. Lurk JT, DeJong DJ, Woods TM, et al. Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider setting. Am J Health Syst Pharm 2004 61 : 267 72.
19. Nelson AA Reeder CE, Dickson WM. The effect of a Medicaid drug co-payment program on the utilization and cost of prescription services. Med Care 1984 22 : 724 36.
20. Ellis E, Smith V, Rosseau D. Medicaid Enrollment in 50 States: June 2003 Data Update. Washington, DC : The Kaiser Commission on Medicaid and Uninsured, 2004.
21. Bair YA, Garcia JA, Romano PS, et al. Does "mainstreaming" guarantee access to care for Medicaid recipients with asthma? J Gen Intern Med 2001 16 : 475 81.
22. SRBI. Asthma in America, Executive Survey. Available at: http://www.asthmainamerica.com/slides/slide20.htm, 1998.
23. Adams RJ, Fuhlbrigge A, Guilbert T, et al. Inadequate use of asthma medication in the United States: results of the Asthma in America national population survey. J Allergy Clin Immunol 2002 110 : 58 64.
24. Piecoro LT, Potoski M, Talbert JC, et al. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Health Serv Res 2001 36 : 357 71.
25. Ellemberg CM, Nguyen TQ, Waniewski P, et al. New York State Asthma Medicaid Surveillance Activities. New York : New York State Department of Health, 2001.
26. Anarella J, Roohan P, Balistreri E, et al. A survey of Medicaid recipients with asthma: perceptions of self-management, access, and care. Chest 2004 125 : 1359 67.
27. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making 1983 3 : 419 58.
28. National Asthma Education and Prevention Program. NAEPP Expert Panel Report for the Guidelines and Management of Asthma-Updated on Selected Topics 2002. Bethesda, MD : National Institute of Health, US Department of Health and Human Services, 2003.
29. De Palo VA, Mayo PH, Friedman P, et al. Demographic influences on asthma hospital admission rates in New York City. Chest 1994 106 : 447 51.
30. Thomas SD, Whitman S. Asthma hospitalizations and mortality in Chicago: an epidemiologic overview. Chest 1999 116 (4 Suppl. 1 S135 41.
31. National Institute of Health. Asthma Statistics. Bethesda, MD : U.S. Department of Health and Human Services, 1999.
32. Stanford R, Mclaughlin T, Okamoto L. The cost of asthma in the emergency department and hospital. Am J Respir Crit Care Med 1999 160 : 211 15.
33. Segal R, Ried LD, Mackowiak J. Cost of asthma illnesses: emergency department visits without admission. Pharm Pract Manag Q 1995 15 : 72 82.
34. Coventry JA, Weston MS, Collins PM. Emergency room encounters of pediatric patients with asthma: cost comparisons with other treatment settings. J Ambul Care Manage 1996 19 : 9 21.
35. US Census Bureau. Statistical Abstract of the United States: 2004. Washington, DC : US Department of Commerce, Economics and Statistics Administration, 2005.
36. Hearle K, The Lewin Group. Memorandum to Secretary of Administration and Finance, House Clerk Office, House and State Committee on Ways and Means, Analysis of Reimbursement Rate for Acute Hospitals. Non-Acute Hosptials, and Community Health Centers. Masschusetts Hospital Association, 2001.
37. Department of Health and Human Services, Department of Secretary. Federal financial participation in state assistance expenditure. Fed Regist 2003 67 : 35889 90.
38. Medical Economics. Physician's Desk Reference (57 ed.). Montvale, NJ : Thomson PDR, 2003.
39. Medical Economics. Drug Topics Red Book. Montvale, NJ : Thomson PDR, 2003.
40. Division of Health Care Financing and Policy. Quarterly Acute Hospital Finance Report, FY Q2. Boston, MA : Commonwealth of Massachusetts, 2004.
41. The Medicaid Access Study Group. Access of Medicaid recipients to oupatient care. N Engl J Med 1994 330 : 1426 30.
42. Carrasquillo O, Himmelstein DU, Woolhandler S, et al. Can Medicaid managed care provide continuity of care to new Medicaid enrollees? An analysis of tenure on Medicaid. Am J Public Health 1998 88 : 464 6.
43. Congressional Budget Office. Medicaid's Reimbursement to Pharmacies for Prescription Drugs. Washington, DC : The Congress of the United States, Congressional Budget Office, 2004.
44. Wagner VL, Radigan MS, Roohan PJ, et al. Asthma in Medicaid managed care enrollees residing in New York City: results from a post-World Trade Center disaster survey. J Urban Health 2005 82 : 76 89.
45. Thomas P, Ross RN, Farrar JR. A retrospective assessment of cost avoidance associated with the use of nedocromil sodium metered-dose inhaler in the treatment of patients with asthma. Clin Ther 1996 18 : 939 52.
46. Bailey WC, Higgins DM, Richards BM, et al. Asthma severity: a factor analytic investigation. Am J Med 1992 93 : 263 9.